These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 160637)

  • 1. Immune response to weakly immunogenic virally induced tumors. IV. Dissociated recognition of H-2 and tumor-associated antigens.
    Devens B; Naor D; Kedar E
    Transplantation; 1979 Nov; 28(5):389-95. PubMed ID: 160637
    [No Abstract]   [Full Text] [Related]  

  • 2. H-2 restriction of adoptive immunotherapy of advanced tumors.
    Greenberg PD; Cheever MA; Fefer A
    J Immunol; 1981 Jun; 126(6):2100-3. PubMed ID: 6453154
    [No Abstract]   [Full Text] [Related]  

  • 3. Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K.
    Schmidt W; Leben L; Atfield G; Festenstein H
    Immunogenetics; 1981; 14(3-4):323-39. PubMed ID: 7333657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated anti-tumor response in the RLmale 1 system. I. T nature, H-2Dd involvement and antigenic specificity of the effector cells.
    Duprez V; Gomard E; Levy JP
    Eur J Immunol; 1978 Sep; 8(9):650-5. PubMed ID: 81780
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC; Rodrigues D; Igarashi T
    J Immunol; 1979 Apr; 122(4):1510-8. PubMed ID: 221575
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic variation in cancer metastasis: immune escape versus immune control.
    Schirrmacher V; Fogel M; Russmann E; Bosslet K; Altevogt P; Beck L
    Cancer Metastasis Rev; 1982; 1(3):241-74. PubMed ID: 6985248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells.
    Brandchaft PB; Aoki T; Silverman TN
    Int J Cancer; 1976 May; 17(5):678-85. PubMed ID: 57937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune responses to weakly immunogenic virally induced tumors. VI. Comparison of the immune response of the hybrid to the immune responses of the parents reveals "hybrid responsiveness" effect.
    Devens B; Naor D
    J Immunol; 1980 Sep; 125(3):988-94. PubMed ID: 6447725
    [No Abstract]   [Full Text] [Related]  

  • 12. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC; Law LW
    J Immunol; 1977 Apr; 118(4):1259-64. PubMed ID: 191534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the recognition and lysis of EL4 tumor target cells by cytotoxic T lymphocytes.
    Gilmer PJ; Figard SD; Flores RV; DiRoma PJ
    Cell Immunol; 1982 Nov; 73(2):337-48. PubMed ID: 6984363
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of cell-mediated immunity against leukemia EL4 in C57BL mice.
    Kemp A; Berke G; Crowell J; Amos B
    J Natl Cancer Inst; 1973 Dec; 51(6):1877-82. PubMed ID: 4765391
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune responses and tolerance to donor tissue in nude mice grafted with an allogeneic thymus.
    Kindred B
    Haematol Blood Transfus; 1980; 25():3-9. PubMed ID: 6455336
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1747-53. PubMed ID: 6452477
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal transplantation tolerance results from two types of suppression acting during induction and at the effector phase.
    Streilein JW; Gruchalla RS; Strome P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):578-81. PubMed ID: 7268884
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.